Sign up to save your podcasts
Or
Share The Lancet Neurology: November 16, 2010
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Neurology: November 16, 2010
Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
View all episodes
By The Lancet NeurologyDiscussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
More shows like In conversation with...
View all
Hidden Brain
43,687 Listeners
Neurology® Podcast
299 Listeners
Learning English Vocabulary
503 Listeners
Practical Neurology Podcast
53 Listeners
The Daily
113,121 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
518 Listeners
Neurology Exam Prep Podcast
189 Listeners
NEJM AI Grand Rounds
59 Listeners
Continuum Audio
80 Listeners
eanCast: Weekly Neurology
0 Listeners